logo
Plus   Neg
Share
Email

Amgen Offers To Buy Nuevolution For SEK 32.50/shr In Cash - Quick Facts

Amgen Inc. (AMGN) said that it has offered to buy Nuevolution AB for 32.50 Swedish kronor per share in cash, valuing the company at about 1.610 billion kronor or $167 million.

The offer price represented a premium of 169% compared to the closing price of Nuevolution's shares on Nasdaq Stockholm on 21 May 2019 of 12.10 kronor.

Nuevolution's Board recommended its shareholders to accept the Offer. Nuevolution is a small molecule drug discovery platform biotech company founded in 2001, headquartered in Copenhagen, Denmark.

The acceptance period for the Offer is expected to commence on or around 13 June 2019 and expire on or around 4 July 2019. Settlement is expected to take place on or around 15 July 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A survey has shown that while a majority of Americans want to buy a car that contributes substantially to the U.S. economy amid rising trade tensions, most of the "American-made" cars are actually produced by foreign automakers. According to Cars.com's 2019 American-Made Index, the most 'American-made' vehicle in 2019 is the Jeep Cherokee. Streaming giant Netflix Inc. (NFXL) is set to lose the right to stream "The Office," one of the most popular TV show on the service. NBC Universal announced it is taking back the popular TV show for its own streaming platform, beginning January 2021. "We're sad that NBC has decided to take The... Chinese smartphone maker Xiaomi has announced that its recently launched Mi Band 4 crossed 1 million units sales in just eight days. Xiaomi's Director of Product Management Donovan Sung tweeted this news as he thanked Mi fans for the achievement. "Sharing some great news with our global Mi Fans....
Follow RTT